tiprankstipranks
Alterity Therapeutics Ltd. (PRNAF)
OTHER OTC:PRNAF
US Market
PRNAF
Alterity Therapeutics
RESEARCH TOOLSreports
Want to see PRNAF full AI Analyst Report?

Alterity Therapeutics (PRNAF) Stock News & Sentiment

5 Followers
Alterity Therapeutics Showcases MSA Program Ahead of Phase 3 Push
Premium
Company Announcements
Alterity Therapeutics Showcases MSA Program Ahead of Phase 3 Push
4d ago
Alterity advances ATH434 toward Phase 3 in Multiple System Atrophy after FDA backing
Premium
Company Announcements
Alterity advances ATH434 toward Phase 3 in Multiple System Atrophy after FDA backing
11d ago
Alterity Therapeutics Sets Virtual General Meeting for May 29, 2026
Premium
Company Announcements
Alterity Therapeutics Sets Virtual General Meeting for May 29, 2026
12d ago
Alterity Wins FDA Backing on CMC Plan for ATH434 Phase 3 in Multiple System Atrophy
Premium
Company Announcements
Alterity Wins FDA Backing on CMC Plan for ATH434 Phase 3 in Multiple System Atrophy
14d ago
Alterity’s ATH434 Shows Phase 2 Efficacy Signal in MSA on New Composite Scale
Premium
Company Announcements
Alterity’s ATH434 Shows Phase 2 Efficacy Signal in MSA on New Composite Scale
19d ago
Alterity Therapeutics Names Ann Cunningham to Board With No Initial Shareholding
Premium
Company Announcements
Alterity Therapeutics Names Ann Cunningham to Board With No Initial Shareholding
20d ago
Alterity Therapeutics Grants 27 Million Unlisted Options Under Incentive Scheme
Premium
Company Announcements
Alterity Therapeutics Grants 27 Million Unlisted Options Under Incentive Scheme
20d ago
More PRNAF News >

PRNAF News on the Web

Alterity Therapeutics appoints Cunningham to Board of Directors
TipRanks News
Neutral
StockTake: Alterity Therapeutics adds industry veteran to board
StockHead
Bullish
Alterity Therapeutics Adds Veteran Biotech Executive Ann Cunningham to Board
TipRanks News
Bullish
Alterity to Spotlight ATH434 MSA Data in Late-Breaker at AAN Meeting
TipRanks News
Bullish
Alterity Therapeutics Showcases ATH434 Progress in Virtual MSA KOL Event
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Alterity Therapeutics (OtherPRNAF), Tarsus Pharmaceuticals (TARS) and enGene Holdings (ENGN)
TipRanks News
Bullish
Alterity gains positive FDA feedback ahead of phase III MSA trial
StockHead
Bullish
Alterity Flags Risks Around Forward‑Looking Corporate Outlook
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
PRNAF
Sector Average
Media Buzz
This Week5 articles
Weekly Average2.75 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PRNAF’s Media Buzz Sentiment?
5 articles about PRNAF were published this week. In an average week, 2.75 articles are published.
    What is PRNAF’s weekly average amount of articles?
    In an average week, 2.75 articles about PRNAF are published.
      What is PRNAF’s News Sentiment?
      100% of articles about PRNAF were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week